Summary of findings 3. Chlorhexadine 4% compared with no wash.
Chlorhexadine 4% compared to no wash for surgical patients | ||||||
Patient or population: surgical patients Settings: Hospital Intervention: Chlorhexadine 4% Comparison: no wash | ||||||
Outcomes | Illustrative comparative risks* (95% CI) | Relative effect (95% CI) | No of Participants (studies) | Quality of the evidence (GRADE) | Comments | |
Assumed risk | Corresponding risk | |||||
no wash | Chlorhexadine 4% | |||||
Surgical site infection Follow‐up: 1 ‐ 3 weeks1 | Study population | RR 0.82 (0.26 to 2.62) | 1142 (3 studies) | ⊕⊝⊝⊝ very low2,3,4 | ||
56 per 1000 | 46 per 1000 (15 to 147) | |||||
Medium risk population | ||||||
46 per 1000 | 38 per 1000 (12 to 121) | |||||
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: Confidence interval; RR: Risk ratio; | ||||||
GRADE Working Group grades of evidence High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality: We are very uncertain about the estimate. |
1 Some studies followed patients only until hospital discharge; as the studies were over 20 years old, we have assumed this to be one week. 2 A number of potential biases existed including inadequate allocation concealment and blinding. 3 Hetrogeneity between studies was evident; this was most likely due to different types of surgeries, differences in length of follow‐up, varying sample sizes and ways of defining infection. 4 Wide confidence intervals, low event rate.